Skip to main content
. 2020 Oct 26;22(6):5135–5144. doi: 10.3892/mmr.2020.11637

Figure 6.

Figure 6.

The presence of TLR4 agonist-LPS blunts the effect of eupafolin. (A) TCC staining images of brain tissues in rats at 24 h after cerebral I/R. (B) Histogram of cerebral infarction volume in different groups. **P<0.01 vs. eupafolin 20 mg/kg. I/R, ischemia/reperfusion; TTC, 2,3,5-triphenyltetrazolium chloride; LPS, lipopolysaccharide.